Provider: NIHR Journals Library
Content:text/plain; charset="UTF-8"
TY  - JOUR
LB  - 1.
AU  - Steegers, EA
AU  - von Dadelszen, P
AU  - Duvekot, JJ
AU  - Pijnenborg, R
TI  - Pre-eclampsia
J2  - Lancet
PY  - 2010
VL  - 376
SP  - 631
EP  - 644
UR  - https://doi.org/10.1016/S0140-6736(10)60279-6
ER  - 
TY  - JOUR
LB  - 2.
AU  - Irgens, HU
AU  - Reisaeter, L
AU  - Irgens, LM
AU  - Lie, RT
TI  - Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study
J2  - BMJ
PY  - 2001
VL  - 323
SP  - 1213
EP  - 1217
UR  - https://doi.org/10.1136/bmj.323.7323.1213
ER  - 
TY  - JOUR
LB  - 3.
AU  - Souza, JP
AU  - Gülmezoglu, AM
AU  - Vogel, J
AU  - Carroli, G
AU  - Lumbiganon, P
AU  - Qureshi, Z
TI  - Moving beyond essential interventions for reduction of maternal mortality (the WHO Multicountry Survey on Maternal and Newborn Health): a cross-sectional study
J2  - Lancet
PY  - 2013
VL  - 381
SP  - 1747
EP  - 1755
UR  - https://doi.org/10.1016/S0140-6736(13)60686-8
ER  - 
TY  - JOUR
LB  - 4.
AU  - Saleem, S
AU  - McClure, EM
AU  - Goudar, SS
AU  - Patel, A
AU  - Esamai, F
AU  - Garces, A
TI  - A prospective study of maternal, fetal and neonatal deaths in low- and middle-income countries
J2  - Bull World Health Organ
PY  - 2014
VL  - 92
SP  - 605
EP  - 612
UR  - https://doi.org/10.2471/BLT.13.127464
ER  - 
TY  - JOUR
LB  - 5.
AU  - Lisonkova, S
AU  - Joseph, KS
TI  - Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease
J2  - Am J Obstet Gynecol
PY  - 2013
VL  - 209
SP  - 544
SP  - e1
EP  - 544.e12
UR  - https://doi.org/10.1016/j.ajog.2013.08.019
ER  - 
TY  - JOUR
LB  - 6.
AU  - Askie, LM
AU  - Duley, L
AU  - Henderson-Smart, DJ
AU  - Stewart, LA
AU  - PARIS Collaborative Group
TI  - Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data
J2  - Lancet
PY  - 2007
VL  - 369
SP  - 1791
EP  - 1798
UR  - https://doi.org/10.1016/S0140-6736(07)60712-0
ER  - 
TY  - JOUR
LB  - 7.
AU  - Rolnik, DL
AU  - Wright, D
AU  - Poon, LC
AU  - O’Gorman, N
AU  - Syngelaki, A
AU  - de Paco Matallana, C
TI  - Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia
J2  - N Engl J Med
PY  - 2017
VL  - 377
SP  - 613
EP  - 622
UR  - https://doi.org/10.1056/NEJMoa1704559
ER  - 
TY  - GEN
LB  - 8.
AU  - National Collaborating Centre for Women’s and Children’s Health (UK)
TI  - Hypertension in Pregnancy: The Management of Hypertensive Disorders During Pregnancy
CY  - London
PB  - Royal College of Obstetricians & Gynaecologists Press
PY  - 2010
ER  - 
TY  - GEN
LB  - 9.
AU  - NICE
TI  - Hypertension in Pregnancy: Diagnosis and Management. NICE guideline [NG133]
CY  - London
PB  - NICE
PY  - 2019
UR  - www.nice.org.uk/guidance/ng133
Y2  - October 2020
ER  - 
TY  - JOUR
LB  - 10.
AU  - Allotey, J
AU  - Snell, KIE
AU  - Chan, C
AU  - Hooper, R
AU  - Dodds, J
AU  - Rogozinska, E
TI  - External validation, update and development of prediction models for pre-eclampsia using an individual participant data (IPD) meta-analysis: the International Prediction of Pregnancy Complication Network (IPPIC pre-eclampsia) protocol
J2  - Diagn Progn Res
PY  - 2017
VL  - 1
SP  - 16
UR  - https://doi.org/10.1186/s41512-017-0016-z
ER  - 
TY  - JOUR
LB  - 11.
AU  - Royston, P
AU  - Thompson, SG
TI  - Model-based screening by risk with application to Down’s syndrome
J2  - Stat Med
PY  - 1992
VL  - 11
SP  - 257
EP  - 268
UR  - https://doi.org/10.1002/sim.4780110211
ER  - 
TY  - JOUR
LB  - 12.
AU  - Plasencia, W
AU  - Maiz, N
AU  - Bonino, S
AU  - Kaihura, C
AU  - Nicolaides, KH
TI  - Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre-eclampsia
J2  - Ultrasound Obstet Gynecol
PY  - 2007
VL  - 30
SP  - 742
EP  - 749
UR  - https://doi.org/10.1002/uog.5157
ER  - 
TY  - JOUR
LB  - 13.
AU  - Akolekar, R
AU  - Zaragoza, E
AU  - Poon, LC
AU  - Pepes, S
AU  - Nicolaides, KH
TI  - Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia
J2  - Ultrasound Obstet Gynecol
PY  - 2008
VL  - 32
SP  - 732
EP  - 739
UR  - https://doi.org/10.1002/uog.6244
ER  - 
TY  - JOUR
LB  - 14.
AU  - Poon, LC
AU  - Kametas, NA
AU  - Pandeva, I
AU  - Valencia, C
AU  - Nicolaides, KH
TI  - Mean arterial pressure at 11(+ 0) to 13(+ 6) weeks in the prediction of preeclampsia
J2  - Hypertension
PY  - 2008
VL  - 51
SP  - 1027
EP  - 1033
UR  - https://doi.org/10.1161/HYPERTENSIONAHA.107.104646
ER  - 
TY  - JOUR
LB  - 15.
AU  - Poon, LC
AU  - Maiz, N
AU  - Valencia, C
AU  - Plasencia, W
AU  - Nicolaides, KH
TI  - First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia
J2  - Ultrasound Obstet Gynecol
PY  - 2009
VL  - 33
SP  - 23
EP  - 33
UR  - https://doi.org/10.1002/uog.6280
ER  - 
TY  - JOUR
LB  - 16.
AU  - Poon, LC
AU  - Kametas, NA
AU  - Valencia, C
AU  - Chelemen, T
AU  - Nicolaides, KH
TI  - Hypertensive disorders in pregnancy: screening by systolic diastolic and mean arterial pressure at 11–13 weeks
J2  - Hypertens Pregnancy
PY  - 2011
VL  - 30
SP  - 93
EP  - 107
UR  - https://doi.org/10.3109/10641955.2010.484086
ER  - 
TY  - JOUR
LB  - 17.
AU  - O’Gorman, N
AU  - Wright, D
AU  - Syngelaki, A
AU  - Akolekar, R
AU  - Wright, A
AU  - Poon, LC
AU  - Nicolaides, KH
TI  - Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11–13 weeks gestation
J2  - Am J Obstet Gynecol
PY  - 2016
VL  - 214
SP  - 103
SP  - e1
EP  - 103.e12
UR  - https://doi.org/10.1016/j.ajog.2015.08.034
ER  - 
TY  - JOUR
LB  - 18.
AU  - Wright, D
AU  - Akolekar, R
AU  - Syngelaki, A
AU  - Poon, LC
AU  - Nicolaides, KH
TI  - A competing risks model in early screening for preeclampsia
J2  - Fetal Diagn Ther
PY  - 2012
VL  - 32
SP  - 171
EP  - 178
UR  - https://doi.org/10.1159/000338470
ER  - 
TY  - JOUR
LB  - 19.
AU  - Akolekar, R
AU  - Syngelaki, A
AU  - Poon, L
AU  - Wright, D
AU  - Nicolaides, KH
TI  - Competing risks model in early screening for preeclampsia by biophysical and biochemical markers
J2  - Fetal Diagn Ther
PY  - 2013
VL  - 33
SP  - 8
EP  - 15
UR  - https://doi.org/10.1159/000341264
ER  - 
TY  - JOUR
LB  - 20.
AU  - Wald, NJ
AU  - Cuckle, H
AU  - Brock, JH
AU  - Peto, R
AU  - Polani, PE
AU  - Woodford, FP
TI  - Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects
J2  - Lancet
PY  - 1977
VL  - 1
SP  - 1323
EP  - 1332
UR  - https://doi.org/10.1016/S0140-6736(77)92549-1
ER  - 
TY  - JOUR
LB  - 21.
AU  - American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy
TI  - Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy
J2  - Obstet Gynecol
PY  - 2013
VL  - 122
SP  - 1122
EP  - 1131
UR  - https://doi.org/10.1097/01.AOG.0000437382.03963.88
ER  - 
TY  - JOUR
LB  - 22.
AU  - American College of Obstetricians and Gynecologists Committee opinion no
TI  - 743: low-dose aspirin use during pregnancy
J2  - Obstet Gynecol
PY  - 2018
VL  - 132
SP  - e44
EP  - e52
UR  - https://doi.org/10.1097/AOG.0000000000002708
ER  - 
TY  - JOUR
LB  - 23.
AU  - Goetzinger, KR
AU  - Singla, A
AU  - Gerkowicz, S
AU  - Dicke, JM
AU  - Gray, DL
AU  - Odibo, AO
TI  - Predicting the risk of pre-eclampsia between 11 and 13 weeks’ gestation by combining maternal characteristics and serum analytes, PAPP-A and free β-hCG
J2  - Prenat Diagn
PY  - 2010
VL  - 30
SP  - 1138
EP  - 1142
UR  - https://doi.org/10.1002/pd.2627
ER  - 
TY  - JOUR
LB  - 24.
AU  - Poon, LC
AU  - Kametas, NA
AU  - Chelemen, T
AU  - Leal, A
AU  - Nicolaides, KH
TI  - Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach
J2  - J Hum Hypertens
PY  - 2010
VL  - 24
SP  - 104
EP  - 110
UR  - https://doi.org/10.1038/jhh.2009.45
ER  - 
TY  - JOUR
LB  - 25.
AU  - Odibo, AO
AU  - Zhong, Y
AU  - Goetzinger, KR
AU  - Odibo, L
AU  - Bick, JL
AU  - Bower, CR
AU  - Nelson, DM
TI  - First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia
J2  - Placenta
PY  - 2011
VL  - 32
SP  - 598
EP  - 602
UR  - https://doi.org/10.1016/j.placenta.2011.05.006
ER  - 
TY  - JOUR
LB  - 26.
AU  - Kuc, S
AU  - Koster, MP
AU  - Franx, A
AU  - Schielen, PC
AU  - Visser, GH
TI  - Maternal characteristics, mean arterial pressure and serum markers in early prediction of preeclampsia
J2  - PLOS ONE
PY  - 2013
VL  - 8
SP  - e63546
UR  - https://doi.org/10.1371/journal.pone.0063546
ER  - 
TY  - JOUR
LB  - 27.
AU  - Scazzocchio, E
AU  - Figueras, F
AU  - Crispi, F
AU  - Meler, E
AU  - Masoller, N
AU  - Mula, R
AU  - Gratacos, E
TI  - Performance of a first-trimester screening of preeclampsia in a routine care low-risk setting
J2  - Am J Obstet Gynecol
PY  - 2013
VL  - 208
SP  - 203
SP  - e1
EP  - 203.e10
UR  - https://doi.org/10.1016/j.ajog.2012.12.016
ER  - 
TY  - JOUR
LB  - 28.
AU  - Baschat, AA
AU  - Magder, LS
AU  - Doyle, LE
AU  - Atlas, RO
AU  - Jenkins, CB
AU  - Blitzer, MG
TI  - Prediction of preeclampsia utilizing the first trimester screening examination
J2  - Am J Obstet Gynecol
PY  - 2014
VL  - 211
SP  - 514
SP  - e1
EP  - e7
UR  - https://doi.org/10.1016/j.ajog.2014.04.018
ER  - 
TY  - JOUR
LB  - 29.
AU  - Crovetto, F
AU  - Figueras, F
AU  - Triunfo, S
AU  - Crispi, F
AU  - Rodriguez-Sureda, V
AU  - Dominguez, C
TI  - First trimester screening for early and late preeclampsia based on maternal characteristics, biophysical parameters, and angiogenic factors
J2  - Prenat Diagn
PY  - 2015
VL  - 35
SP  - 183
EP  - 191
UR  - https://doi.org/10.1002/pd.4519
ER  - 
TY  - JOUR
LB  - 30.
AU  - Tan, MY
AU  - Koutoulas, L
AU  - Wright, D
AU  - Nicolaides, KH
AU  - Poon, LCY
TI  - Protocol for the prospective validation study: ‘screening programme for pre-eclampsia’ (SPREE)
J2  - Ultrasound Obstet Gynecol
PY  - 2017
VL  - 50
SP  - 175
EP  - 179
UR  - https://doi.org/10.1002/uog.17467
ER  - 
TY  - JOUR
LB  - 31.
AU  - Robinson, HP
AU  - Fleming, JE
TI  - A critical evaluation of sonar ‘crown-rump length’ measurements
J2  - Br J Obstet Gynaecol
PY  - 1975
VL  - 82
SP  - 702
EP  - 710
ER  - 
TY  - JOUR
LB  - 32.
AU  - Poon, LC
AU  - Zymeri, NA
AU  - Zamprakou, A
AU  - Syngelaki, A
AU  - Nicolaides, KH
TI  - Protocol for measurement of mean arterial pressure at 11–13 weeks’ gestation
J2  - Fetal Diagn Ther
PY  - 2012
VL  - 31
SP  - 42
EP  - 48
UR  - https://doi.org/10.1159/000335366
ER  - 
TY  - JOUR
LB  - 33.
AU  - Wright, D
AU  - Syngelaki, A
AU  - Akolekar, R
AU  - Poon, LC
AU  - Nicolaides, KH
TI  - Competing risks model in screening for preeclampsia by maternal characteristics and medical history
J2  - Am J Obstet Gynecol
PY  - 2015
VL  - 213
SP  - 62
SP  - e1
EP  - 62.e10
UR  - https://doi.org/10.1016/j.ajog.2015.02.018
ER  - 
TY  - JOUR
LB  - 34.
AU  - Brown, MA
AU  - Lindheimer, MD
AU  - de Swiet, M
AU  - Van Assche, A
AU  - Moutquin, JM
TI  - The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)
J2  - Hypertens Pregnancy
PY  - 2001
VL  - 20
SP  - IX
EP  - XIV
UR  - https://doi.org/10.1081/PRG-100104165
ER  - 
TY  - JOUR
LB  - 35.
AU  - Wright, D
AU  - Tan, MY
AU  - O’Gorman, N
AU  - Poon, LC
AU  - Syngelaki, A
AU  - Wright, A
AU  - Nicolaides, KH
TI  - Predictive performance of the competing risk model in screening for preeclampsia
J2  - Am J Obstet Gynecol
PY  - 2019
VL  - 220
SP  - 199
SP  - e1
EP  - 199.e13
UR  - https://doi.org/10.1016/j.ajog.2018.11.1087
ER  - 
TY  - BOOK
LB  - 36.
AU  - Gilk, W
AU  - Richardson, S
AU  - Spiegelhalter, D
TI  - Markov Chain Monte Carlo in Practice
CY  - Boca Raton, FL
PB  - Chapman & Hall
PY  - 1998
ER  - 
TY  - JOUR
LB  - 37.
AU  - Bossuyt, PM
AU  - Reitsma, JB
AU  - Bruns, DE
AU  - Gatsonis, CA
AU  - Glasziou, PP
AU  - Irwig, L
TI  - STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies
J2  - BMJ
PY  - 2015
VL  - 351
SP  - h5527
UR  - https://doi.org/10.1136/bmj.h5527
ER  - 
TY  - JOUR
LB  - 38.
AU  - Tan, MY
AU  - Wright, D
AU  - Syngelaki, A
AU  - Akolekar, R
AU  - Cicero, S
AU  - Janga, D
TI  - Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE
J2  - Ultrasound Obstet Gynecol
PY  - 2018
VL  - 51
SP  - 743
EP  - 750
UR  - https://doi.org/10.1002/uog.19039
ER  - 
TY  - JOUR
LB  - 39.
AU  - O’Gorman, N
AU  - Wright, D
AU  - Poon, LC
AU  - Rolnik, DL
AU  - Syngelaki, A
AU  - Wright, A
TI  - Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation
J2  - Ultrasound Obstet Gynecol
PY  - 2017
VL  - 49
SP  - 751
EP  - 755
UR  - https://doi.org/10.1002/uog.17399
ER  - 
TY  - JOUR
LB  - 40.
AU  - Rolnik, DL
AU  - Wright, D
AU  - Poon, LCY
AU  - Syngelaki, A
AU  - O’Gorman, N
AU  - de Paco Matallana, C
TI  - ASPRE trial: performance of screening for preterm pre-eclampsia
J2  - Ultrasound Obstet Gynecol
PY  - 2017
VL  - 50
SP  - 492
EP  - 495
UR  - https://doi.org/10.1002/uog.18816
ER  - 
TY  - JOUR
LB  - 41.
AU  - Oliveira, N
AU  - Magder, LS
AU  - Blitzer, MG
AU  - Baschat, AA
TI  - First-trimester prediction of pre-eclampsia: external validity of algorithms in a prospectively enrolled cohort
J2  - Ultrasound Obstet Gynecol
PY  - 2014
VL  - 44
SP  - 279
EP  - 285
UR  - https://doi.org/10.1002/uog.13435
ER  - 
TY  - JOUR
LB  - 42.
AU  - Al-Rubaie, Z
AU  - Askie, LM
AU  - Ray, JG
AU  - Hudson, HM
AU  - Lord, SJ
TI  - The performance of risk prediction models for pre-eclampsia using routinely collected maternal characteristics and comparison with models that include specialised tests and with clinical guideline decision rules: a systematic review
J2  - BJOG
PY  - 2016
VL  - 123
SP  - 1441
EP  - 1452
UR  - https://doi.org/10.1111/1471-0528.14029
ER  - 
TY  - JOUR
LB  - 43.
AU  - Wright, D
AU  - Poon, LC
AU  - Rolnik, DL
AU  - Syngelaki, A
AU  - Delgado, JL
AU  - Vojtassakova, D
TI  - Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia
J2  - Am J Obstet Gynecol
PY  - 2017
VL  - 217
SP  - 685
SP  - e1
EP  - 685.e5
UR  - https://doi.org/10.1016/j.ajog.2017.08.110
ER  - 
TY  - JOUR
LB  - 44.
AU  - Tayyar, A
AU  - Guerra, L
AU  - Wright, A
AU  - Wright, D
AU  - Nicolaides, KH
TI  - Uterine artery pulsatility index in the three trimesters of pregnancy: effects of maternal characteristics and medical history
J2  - Ultrasound Obstet Gynecol
PY  - 2015
VL  - 45
SP  - 689
EP  - 697
UR  - https://doi.org/10.1002/uog.14789
ER  - 
TY  - JOUR
LB  - 45.
AU  - Tsiakkas, A
AU  - Duvdevani, N
AU  - Wright, A
AU  - Wright, D
AU  - Nicolaides, KH
TI  - Serum placental growth factor in the three trimesters of pregnancy: effects of maternal characteristics and medical history
J2  - Ultrasound Obstet Gynecol
PY  - 2015
VL  - 45
SP  - 591
EP  - 598
UR  - https://doi.org/10.1002/uog.14811
ER  - 
TY  - JOUR
LB  - 46.
AU  - Wright, A
AU  - Wright, D
AU  - Ispas, CA
AU  - Poon, LC
AU  - Nicolaides, KH
TI  - Mean arterial pressure in the three trimesters of pregnancy: effects of maternal characteristics and medical history
J2  - Ultrasound Obstet Gynecol
PY  - 2015
VL  - 45
SP  - 698
EP  - 706
UR  - https://doi.org/10.1002/uog.14783
ER  - 
TY  - GEN
LB  - 47.
AU  - UK National Screening Committee
TI  - Fetal Anomaly Screening Programme – Screening for Down’s Syndrome: UK NSC Policy Recommendations 2007–10: Model of Best Practice
CY  - London
PB  - Department of Health and Social Care
PY  - 2008
ER  - 
TY  - JOUR
LB  - 48.
AU  - Nicolaides, KH
TI  - Turning the pyramid of prenatal care
J2  - Fetal Diagn Ther
PY  - 2011
VL  - 29
SP  - 183
EP  - 196
UR  - https://doi.org/10.1159/000324320
ER  - 
TY  - BOOK
LB  - 49.
AU  - Therneau, TM
AU  - Grambsch, PM
TI  - Modeling Survival Data: Extending the Cox Model
CY  - New York, NY
PB  - Springer-Verlag
PY  - 2000
UR  - https://doi.org/10.1007/978-1-4757-3294-8
ER  - 
TY  - JOUR
LB  - 50.
AU  - Wright, A
AU  - Wright, D
AU  - Syngelaki, A
AU  - Georgantis, A
AU  - Nicolaides, KH
TI  - Two-stage screening for preterm preeclampsia at 11–13 weeks’ gestation
J2  - Am J Obstet Gynecol
PY  - 2019
VL  - 220
SP  - 197
SP  - e1
EP  - 197.e11
UR  - https://doi.org/10.1016/j.ajog.2018.10.092
ER  - 
TY  - JOUR
LB  - 51.
AU  - Roberge, S
AU  - Bujold, E
AU  - Nicolaides, KH
TI  - Meta-analysis on the effect of aspirin use for prevention of preeclampsia on placental abruption and antepartum hemorrhage
J2  - Am J Obstet Gynecol
PY  - 2018
VL  - 218
SP  - 483
EP  - 489
UR  - https://doi.org/10.1016/j.ajog.2017.12.238
ER  - 
TY  - JOUR
LB  - 52.
AU  - Muttukrishna, S
AU  - Child, TJ
AU  - Groome, NP
AU  - Ledger, WL
TI  - Source of circulating levels of inhibin A, pro alpha C-containing inhibins and activin A in early pregnancy
J2  - Hum Reprod
PY  - 1997
VL  - 12
SP  - 1089
EP  - 1093
UR  - https://doi.org/10.1093/humrep/12.5.1089
ER  - 
TY  - JOUR
LB  - 53.
AU  - Muttukrishna, S
AU  - Knight, PG
AU  - Groome, NP
AU  - Redman, CW
AU  - Ledger, WL
TI  - Activin A and inhibin A as possible endocrine markers for pre-eclampsia
J2  - Lancet
PY  - 1997
VL  - 349
SP  - 1285
EP  - 1288
UR  - https://doi.org/10.1016/S0140-6736(96)09264-1
ER  - 
TY  - JOUR
LB  - 54.
AU  - Sebire, NJ
AU  - Roberts, L
AU  - Noble, P
AU  - Wallace, E
AU  - Nicolaides, KH
TI  - Raised maternal serum inhibin A concentration at 10 to 14 weeks of gestation is associated with pre-eclampsia
J2  - BJOG
PY  - 2000
VL  - 107
SP  - 795
EP  - 797
UR  - https://doi.org/10.1111/j.1471-0528.2000.tb13343.x
ER  - 
TY  - JOUR
LB  - 55.
AU  - Spencer, K
AU  - Cowans, NJ
AU  - Nicolaides, KH
TI  - Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia
J2  - Ultrasound Obstet Gynecol
PY  - 2008
VL  - 32
SP  - 622
EP  - 626
UR  - https://doi.org/10.1002/uog.6212
ER  - 
TY  - JOUR
LB  - 56.
AU  - Akolekar, R
AU  - Minekawa, R
AU  - Veduta, A
AU  - Romero, XC
AU  - Nicolaides, KH
TI  - Maternal plasma inhibin A at 11–13 weeks of gestation in hypertensive disorders of pregnancy
J2  - Prenat Diagn
PY  - 2009
VL  - 29
SP  - 753
EP  - 760
UR  - https://doi.org/10.1002/pd.2279
ER  - 
TY  - JOUR
LB  - 57.
AU  - Tan, MY
AU  - Syngelaki, A
AU  - Poon, LC
AU  - Rolnik, DL
AU  - O’Gorman, N
AU  - Delgado, JL
TI  - Screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation
J2  - Ultrasound Obstet Gynecol
PY  - 2018
VL  - 52
SP  - 186
EP  - 195
UR  - https://doi.org/10.1002/uog.19112
ER  - 
TY  - JOUR
LB  - 58.
AU  - Yu, CK
AU  - Khouri, O
AU  - Onwudiwe, N
AU  - Spiliopoulos, Y
AU  - Nicolaides, KH
AU  - Fetal Medicine Foundation Second-Trimester Screening Group
TI  - Prediction of pre-eclampsia by uterine artery Doppler imaging: relationship to gestational age at delivery and small-for-gestational age
J2  - Ultrasound Obstet Gynecol
PY  - 2008
VL  - 31
SP  - 310
EP  - 313
UR  - https://doi.org/10.1002/uog.5252
ER  - 
TY  - JOUR
LB  - 59.
AU  - Karagiannis, G
AU  - Akolekar, R
AU  - Sarquis, R
AU  - Wright, D
AU  - Nicolaides, KH
TI  - Prediction of small-for-gestation neonates from biophysical and biochemical markers at 11–13 weeks
J2  - Fetal Diagn Ther
PY  - 2011
VL  - 29
SP  - 148
EP  - 154
UR  - https://doi.org/10.1159/000321694
ER  - 
TY  - JOUR
LB  - 60.
AU  - Tan, MY
AU  - Poon, LC
AU  - Rolnik, DL
AU  - Syngelaki, A
AU  - de Paco Matallana, C
AU  - Akolekar, R
TI  - Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE
J2  - Ultrasound Obstet Gynecol
PY  - 2018
VL  - 52
SP  - 52
EP  - 59
UR  - https://doi.org/10.1002/uog.19077
ER  - 
TY  - JOUR
LB  - 61.
AU  - Nicolaides, KH
AU  - Wright, D
AU  - Syngelaki, A
AU  - Wright, A
AU  - Akolekar, R
TI  - Fetal Medicine Foundation fetal and neonatal population weight charts
J2  - Ultrasound Obstet Gynecol
PY  - 2018
VL  - 52
SP  - 44
EP  - 51
UR  - https://doi.org/10.1002/uog.19073
ER  - 
TY  - JOUR
LB  - 62.
AU  - Wright, D
AU  - Rolnik, DL
AU  - Syngelaki, A
AU  - de Paco Matallana, C
AU  - Machuca, M
AU  - de Alvarado, M
TI  - Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit
J2  - Am J Obstet Gynecol
PY  - 2018
VL  - 218
SP  - 612
SP  - e1
EP  - 612.e6
UR  - https://doi.org/10.1016/j.ajog.2018.02.014
ER  - 
TY  - JOUR
LB  - 63.
AU  - Larroque, B
AU  - Ancel, PY
AU  - Marret, S
AU  - Marchand, L
AU  - André, M
AU  - Arnaud, C
TI  - Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): a longitudinal cohort study
J2  - Lancet
PY  - 2008
VL  - 371
SP  - 813
EP  - 820
UR  - https://doi.org/10.1016/S0140-6736(08)60380-3
ER  - 
TY  - JOUR
LB  - 64.
AU  - Moster, D
AU  - Lie, RT
AU  - Markestad, T
TI  - Long-term medical and social consequences of preterm birth
J2  - N Engl J Med
PY  - 2008
VL  - 359
SP  - 262
EP  - 273
UR  - https://doi.org/10.1056/NEJMoa0706475
ER  - 
TY  - JOUR
LB  - 65.
AU  - Pierrat, V
AU  - Marchand-Martin, L
AU  - Arnaud, C
AU  - Kaminski, M
AU  - Resche-Rigon, M
AU  - Lebeaux, C
TI  - Neurodevelopmental outcome at 2 years for preterm children born at 22 to 34 weeks’ gestation in France in 2011: EPIPAGE-2 cohort study
J2  - BMJ
PY  - 2017
VL  - 358
SP  - j3448
UR  - https://doi.org/10.1136/bmj.j3448
ER  - 
TY  - BOOK
LB  - 66.
AU  - Rubin, DB
TI  - Multiple Imputation for Nonresponse in Surveys
CY  - New York, NY
PB  - John Wiley & Sons
PY  - 1987
UR  - https://doi.org/10.1002/9780470316696
ER  -